{"disease":{"id":"inflammatory-myopathy","name":"inflammatory myopathy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06607471","title":"Multimodal and Multidisciplinary Approach to Optimize Diagnostic, Prognostic, and Therapeutic Management of Patients with Non-ischemic Cardiomyopathies and Arrhythmogenic-inflammatory Phenotypes: a Multicenter, Observational, Retrospective and Prospective Registry Study.","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT07325968","title":"Cardiac MRI in Myocarditis and Inflammatory Cardiomyopathy","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":5000,"lead_sponsor_name":"Chinese Academy of Medical Sciences, Fuwai Hospital","has_results":false},{"nct_id":"NCT07077304","title":"EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT06898762","title":"Creation of a National Multicenter Platform for the Study of Inflammatory Myocardial Disease: Pre-MYO Cohort","phase":"","overall_status":"RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia","has_results":false},{"nct_id":"NCT04521790","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Patients With Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT03430388","title":"Yellow Fever Vaccine in Patients With Rheumatic Diseases","phase":"NA","overall_status":"COMPLETED","enrollment_count":600,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT05982041","title":"Adult Idiopathic Inflammatory Myopathy With Cardiac Injury","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT05869955","title":"A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":270,"lead_sponsor_name":"Juno Therapeutics, Inc., a Bristol-Myers Squibb Company","has_results":false},{"nct_id":"NCT05523167","title":"A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":265,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT04687111","title":"Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":250,"lead_sponsor_name":"Mark Ledwidge","has_results":false},{"nct_id":"NCT04530461","title":"Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"faida agili","has_results":false},{"nct_id":"NCT05961202","title":"The Effects of Hydroxychloroquine in Patients with Inflammatory Cardiomyopathy","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT06158698","title":"CMP-MYTHiC Trial and Registry - CardioMyoPathy With MYocarditis THerapy With Colchicine","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Niguarda Hospital","has_results":false},{"nct_id":"NCT06925542","title":"A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"CRISPR Therapeutics","has_results":false},{"nct_id":"NCT07085676","title":"Phase 1 Study of HBI0101 CAR-T in Refractory B-Cell Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Polina Stepensky","has_results":false},{"nct_id":"NCT06794008","title":"BCMA-CD19 CAR-T Therapy for Refractory Autoimmune Diseases","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT03786913","title":"Quantitative Muscle Ultrasound as a Marker of Progression in Children With Muscular Diseases","phase":"","overall_status":"COMPLETED","enrollment_count":48,"lead_sponsor_name":"Benha University","has_results":false},{"nct_id":"NCT07339540","title":"the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Tongji Hospital","has_results":false},{"nct_id":"NCT03356756","title":"PET MRI Study in Patients With Cardiac Sarcoidosis","phase":"","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT06968819","title":"Virtual Reality and Robotics in Inflammatory Myopathy Rehabilitation","phase":"NA","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland","has_results":false},{"nct_id":"NCT07355257","title":"TELITACICEPT IN INFLAMMATORY MYOPATHIES(TELITACICEPT-IM)","phase":"PHASE2, PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Zhongming Qiu","has_results":false},{"nct_id":"NCT04237987","title":"Low-dose Interleukin-2 in Combination With Standard Therapy on Idiopathic Inflammatory Myopathy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05129410","title":"Clinical Study of MMF in Treatment of IIM-ILD and Its Effect on Peripheral Blood Treg Cells","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT06591260","title":"Role of Endomyocardial Biopsy and Aetiology-based Treatment in Pediatric Patients with Inflammatory Heart Disease in Arrhythmic and Non-arrhythmic Clinical Presentations: an Integrated Approach for the Optimal Diagnostic and Therapeutic Management (MYOPED)","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Scientific Institute San Raffaele","has_results":false},{"nct_id":"NCT07123519","title":"A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07236762","title":"An Exploratory Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07236801","title":"Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06888960","title":"Safety Study of CC312 in Autoimmune Disease Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT07104721","title":"A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07072884","title":"GC012F in Patients With Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":15,"lead_sponsor_name":"Qiong Fu","has_results":false},{"nct_id":"NCT06614270","title":"Anti-CD19 IL-10/IL15 CAR-NK Cells in Refractory/Relapsed Autoimmune Diseases","phase":"NA","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Second Affiliated Hospital, School of Medicine, Zhejiang University","has_results":false},{"nct_id":"NCT04062019","title":"Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":15,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05859997","title":"Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases","phase":"NA","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":15,"lead_sponsor_name":"Bioray Laboratories","has_results":false},{"nct_id":"NCT06941129","title":"CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07413341","title":"A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Therorna","has_results":false},{"nct_id":"NCT06978647","title":"A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT07086404","title":"GC012F Injection in Refractory Idiopathic Inflammatory Myopathy","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Daishi Tian","has_results":false},{"nct_id":"NCT07490275","title":"Allogeneic CD19/BCMA-Targeted CAR-γδT Cell Therapy: Safety and Preliminary Pharmacodynamics in Relapsed/Refractory Autoimmune Diseases","phase":"PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06420154","title":"The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":9,"lead_sponsor_name":"First Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT05570409","title":"Immunosuppressive Treatment in Chronic Virus-Negative Inflammatory Cardiomyopathy","phase":"PHASE2, PHASE3","overall_status":"TERMINATED","enrollment_count":9,"lead_sponsor_name":"LMU Klinikum","has_results":false},{"nct_id":"NCT06379646","title":"An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"China Immunotech (Beijing) Biotechnology Co., Ltd.","has_results":false},{"nct_id":"NCT06373081","title":"Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease","phase":"NA","overall_status":"RECRUITING","enrollment_count":6,"lead_sponsor_name":"Shanghai Changzheng Hospital","has_results":false},{"nct_id":"NCT06462144","title":"IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy","phase":"EARLY_PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","has_results":false},{"nct_id":"NCT05027152","title":"Muscle Function and Effects of Repetitive Task Training in Patients With Inflammatory Myopaties","phase":"NA","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"Federal University of Espirito Santo","has_results":false}],"total":45},"guidelines":[],"source":"Drug Landscape verified database"}